Armenia’s 1.5% inflation in December is the highest since April – WB

YEREVAN, January 29. /ARKA/. Armenia’s inflation picked up to 1.5 percent (yoy) in December, the highest rate since April 2023, according to World Bank’s Armenia Monthly Economic Update – January 2025 review.

This was due to higher inflation for food and nonalcoholic beverages (at 2 percent, yoy, in December, up from 1.7 percent in November); and for healthcare, which rose to 3.2 percent (yoy) in December from 2.5 percent (yoy) in November.

Prices in December continued to decline for clothing and footwear (down 2.6 percent, yoy), furnishings and household equipment (down 2.5 percent, yoy), and housing and utilities (down 0.2 percent, yoy). In 2024, average inflation was 0.3 percent, compared with 2 percent in 2023.  

In Armenia’s state budget for 2025, inflation is set at 3% (±1%). In December, 12-month inflation amounted to 1.5%. According to the Central Bank, 2025 inflation is expected within 3.9-3.2%, the forecast for 2026 is  4.2-3.8%.

spot_img

POPULAR

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

“AGROVISION” CJSC’s bonds were listed on Armenia Stock Exchange

YEREVAN, August 17. /ARKA/.  Today, “AGROVISION” CJSC, a company operating in the agro-industrial sector, became a listed company on the Armenia Stock Exchange (AMX).

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img